Annual Accounts Payable
$3.96 M
+$2.83 M+249.37%
December 31, 2021
Summary
- As of February 7, 2025, STAB annual accounts payable is $3.96 million, with the most recent change of +$2.83 million (+249.37%) on December 31, 2021.
- During the last 3 years, STAB annual accounts payable has risen by +$1.56 million (+64.73%).
- STAB annual accounts payable is now at all-time high.
Performance
STAB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$8.13 M
+$60.30 K+0.75%
September 30, 2022
Summary
- As of February 7, 2025, STAB quarterly accounts payable is $8.13 million, with the most recent change of +$60.30 thousand (+0.75%) on September 30, 2022.
- Over the past year, STAB quarterly accounts payable has increased by +$4.94 million (+155.01%).
- STAB quarterly accounts payable is now at all-time high.
Performance
STAB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
STAB Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +249.4% | +155.0% |
| 3 y3 years | +64.7% | - |
| 5 y5 years | +64.7% | - |
STAB Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +105.1% |
| 5 y | 5-year | at high | +249.4% | at high | +616.5% |
| alltime | all time | at high | +249.4% | at high | +616.5% |
Statera Biopharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $8.13 M(+0.7%) |
| Jun 2022 | - | $8.07 M(+19.7%) |
| Mar 2022 | - | $6.74 M(+70.1%) |
| Dec 2021 | $3.96 M | $3.96 M(+24.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $3.19 M(-51.2%) |
| Jun 2021 | - | $6.54 M(+90.8%) |
| Mar 2021 | - | $3.43 M(+201.9%) |
| Dec 2020 | $1.13 M(-52.9%) | $1.13 M |
| Dec 2019 | $2.41 M | - |
FAQ
- What is Statera Biopharma annual accounts payable?
- What is the all time high annual accounts payable for Statera Biopharma?
- What is Statera Biopharma annual accounts payable year-on-year change?
- What is Statera Biopharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Statera Biopharma?
- What is Statera Biopharma quarterly accounts payable year-on-year change?
What is Statera Biopharma annual accounts payable?
The current annual accounts payable of STAB is $3.96 M
What is the all time high annual accounts payable for Statera Biopharma?
Statera Biopharma all-time high annual accounts payable is $3.96 M
What is Statera Biopharma annual accounts payable year-on-year change?
Over the past year, STAB annual accounts payable has changed by +$2.83 M (+249.37%)
What is Statera Biopharma quarterly accounts payable?
The current quarterly accounts payable of STAB is $8.13 M
What is the all time high quarterly accounts payable for Statera Biopharma?
Statera Biopharma all-time high quarterly accounts payable is $8.13 M
What is Statera Biopharma quarterly accounts payable year-on-year change?
Over the past year, STAB quarterly accounts payable has changed by +$4.94 M (+155.01%)